Jia (Jenny) Liu MD PhD
@jiajennyliu.bsky.social
Early Phase Trials Medical Oncologist / Translational Researcher 👩🏻⚕️ @kinghorncancer St Vincent’s Hospital Sydney Associate Professor @UNSW. MOGA Exec. #PrecisionMedicine #drugdevelopment
Passionate about mentorship ❤️ / wellness 🤸🏻♀️/ communication 🧬📣
Passionate about mentorship ❤️ / wellness 🤸🏻♀️/ communication 🧬📣
Pinned
Oncology drug development 🧬💊 has come a long way, but the system is riddled with inefficiency, inequity and costs are ⏫.
Excited to share our 🌎 review article in press in JCO
@ascocancer.bsky.social
highlighting role of early phase consortia in tackling these challenges: 🧵 1)
#medsky #oncsky
Excited to share our 🌎 review article in press in JCO
@ascocancer.bsky.social
highlighting role of early phase consortia in tackling these challenges: 🧵 1)
#medsky #oncsky
2011 PhD student → 2025 drug development oncologist.
A long road, a lot of growth, and so many people to thank along the way.
Grateful to be promoted to Conjoint Associate Professor at @UNSW.
Excited for the next stage of global collaboration in early phase trials 🧬🧫🔬👩🏻⚕️
A long road, a lot of growth, and so many people to thank along the way.
Grateful to be promoted to Conjoint Associate Professor at @UNSW.
Excited for the next stage of global collaboration in early phase trials 🧬🧫🔬👩🏻⚕️
November 28, 2025 at 7:24 AM
2011 PhD student → 2025 drug development oncologist.
A long road, a lot of growth, and so many people to thank along the way.
Grateful to be promoted to Conjoint Associate Professor at @UNSW.
Excited for the next stage of global collaboration in early phase trials 🧬🧫🔬👩🏻⚕️
A long road, a lot of growth, and so many people to thank along the way.
Grateful to be promoted to Conjoint Associate Professor at @UNSW.
Excited for the next stage of global collaboration in early phase trials 🧬🧫🔬👩🏻⚕️
Congrats @RashaCosman on late breaking oral presentation, showcasing safety and MOA of novel in vivo CAR targeting TROP2 expressing tumors #SITC25 @NECTANSW - led trial from 🇦🇺 👏.
This technology will expand access to solid tumor cell therapy 🌟
This technology will expand access to solid tumor cell therapy 🌟
November 7, 2025 at 7:29 PM
Congrats @RashaCosman on late breaking oral presentation, showcasing safety and MOA of novel in vivo CAR targeting TROP2 expressing tumors #SITC25 @NECTANSW - led trial from 🇦🇺 👏.
This technology will expand access to solid tumor cell therapy 🌟
This technology will expand access to solid tumor cell therapy 🌟
Reposted by Jia (Jenny) Liu MD PhD
One of the Most Insightful Sessions for Me at ESMO 2025 - Jia (Jenny) Liu
@jiajennyliu.bsky.social @myesmo.bsky.social
oncodaily.com/voices/jia-j...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMO #ESMO25 #ESMO2025
@jiajennyliu.bsky.social @myesmo.bsky.social
oncodaily.com/voices/jia-j...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMO #ESMO25 #ESMO2025
Jia (Jenny) Liu: One of the Most Insightful Sessions for Me at ESMO 2025 - OncoDaily
Jia (Jenny) Liu: One of the Most Insightful Sessions for Me at ESMO 2025 / cancer, ESMO, ESMO 2025, ESMO 2025 Congress, ESMO2025, ESMO25, Jean-Yves Blay, Jia
oncodaily.com
October 25, 2025 at 8:01 PM
One of the Most Insightful Sessions for Me at ESMO 2025 - Jia (Jenny) Liu
@jiajennyliu.bsky.social @myesmo.bsky.social
oncodaily.com/voices/jia-j...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMO #ESMO25 #ESMO2025
@jiajennyliu.bsky.social @myesmo.bsky.social
oncodaily.com/voices/jia-j...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMO #ESMO25 #ESMO2025
🌏 Full circle moment — from developing my first trial protocol as a trainee at #ACORD19 to now being elected Deputy Convenor (2026) and incoming Chair of the 🇦🇺/APAC Oncology Research Workshop.
🙏 opportunity to train the next gen of clinical trialists
shorturl.at/RN44X
🙏 opportunity to train the next gen of clinical trialists
shorturl.at/RN44X
October 25, 2025 at 8:42 AM
🌏 Full circle moment — from developing my first trial protocol as a trainee at #ACORD19 to now being elected Deputy Convenor (2026) and incoming Chair of the 🇦🇺/APAC Oncology Research Workshop.
🙏 opportunity to train the next gen of clinical trialists
shorturl.at/RN44X
🙏 opportunity to train the next gen of clinical trialists
shorturl.at/RN44X
Reposted by Jia (Jenny) Liu MD PhD
Insights on ADC Toxicity Strategies in Drug Development from ESMO25 - Jia (Jenny) Liu
@jiajennyliu.bsky.social @ptarantinomd.bsky.social @myesmo.bsky.social
oncodaily.com/voices/adc-t...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMO #ESMO25 #ESMO2025
@jiajennyliu.bsky.social @ptarantinomd.bsky.social @myesmo.bsky.social
oncodaily.com/voices/adc-t...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMO #ESMO25 #ESMO2025
Jia (Jenny) Liu: Insights on ADC Toxicity Strategies in Drug Development from ESMO25 - OncoDaily
Jia (Jenny) Liu: Insights on ADC Toxicity Strategies in Drug Development from ESMO25 / cancer, ESMO, ESMO 2025, ESMO 2025 Congress, ESMO2025, ESMO25, Jia
oncodaily.com
October 20, 2025 at 10:01 PM
Insights on ADC Toxicity Strategies in Drug Development from ESMO25 - Jia (Jenny) Liu
@jiajennyliu.bsky.social @ptarantinomd.bsky.social @myesmo.bsky.social
oncodaily.com/voices/adc-t...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMO #ESMO25 #ESMO2025
@jiajennyliu.bsky.social @ptarantinomd.bsky.social @myesmo.bsky.social
oncodaily.com/voices/adc-t...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMO #ESMO25 #ESMO2025
Reposted by Jia (Jenny) Liu MD PhD
Co-Chairing the Inaugural Tumour-Agnostic Track at ESMO25 - Jia (Jenny) Liu
@jiajennyliu.bsky.social @myesmo.bsky.social
oncodaily.com/voices/jia-l...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMO #ESMO25 #ESMO2025
@jiajennyliu.bsky.social @myesmo.bsky.social
oncodaily.com/voices/jia-l...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMO #ESMO25 #ESMO2025
Jia Liu: Co-Chairing the Inaugural Tumour-Agnostic Track at ESMO25 - OncoDaily
Jia Liu: Co-Chairing the Inaugural Tumour-Agnostic Track at ESMO25 / cancer, ESMO, ESMO 2025, ESMO 2025 Congress, ESMO2025, ESMO25, Jia (Jenny) Liu,
oncodaily.com
October 19, 2025 at 9:48 PM
Co-Chairing the Inaugural Tumour-Agnostic Track at ESMO25 - Jia (Jenny) Liu
@jiajennyliu.bsky.social @myesmo.bsky.social
oncodaily.com/voices/jia-l...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMO #ESMO25 #ESMO2025
@jiajennyliu.bsky.social @myesmo.bsky.social
oncodaily.com/voices/jia-l...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMO #ESMO25 #ESMO2025
D-7 until #ESMO25! 👋🇩🇪
Excited to be part of first ever tumor-agnostic scientific track with @viveksubbiah.bsky.social @JulianaRBeale #NiamhColeman
Don’t miss these educational sessions! ⬇️ @myesmo.bsky.social
Excited to be part of first ever tumor-agnostic scientific track with @viveksubbiah.bsky.social @JulianaRBeale #NiamhColeman
Don’t miss these educational sessions! ⬇️ @myesmo.bsky.social
October 10, 2025 at 8:22 AM
D-7 until #ESMO25! 👋🇩🇪
Excited to be part of first ever tumor-agnostic scientific track with @viveksubbiah.bsky.social @JulianaRBeale #NiamhColeman
Don’t miss these educational sessions! ⬇️ @myesmo.bsky.social
Excited to be part of first ever tumor-agnostic scientific track with @viveksubbiah.bsky.social @JulianaRBeale #NiamhColeman
Don’t miss these educational sessions! ⬇️ @myesmo.bsky.social
EOI for the @MOGA_ORG Mentorship Program #NOMP25 closing soon!
We invite all 🇦🇺 med onc consultants and trainees to sign up. Benefits include networking outside your workplace, support to address career navigation, wellbeing and burnout.
🔗: shorturl.at/pS3Fg
We invite all 🇦🇺 med onc consultants and trainees to sign up. Benefits include networking outside your workplace, support to address career navigation, wellbeing and burnout.
🔗: shorturl.at/pS3Fg
September 12, 2025 at 11:06 PM
EOI for the @MOGA_ORG Mentorship Program #NOMP25 closing soon!
We invite all 🇦🇺 med onc consultants and trainees to sign up. Benefits include networking outside your workplace, support to address career navigation, wellbeing and burnout.
🔗: shorturl.at/pS3Fg
We invite all 🇦🇺 med onc consultants and trainees to sign up. Benefits include networking outside your workplace, support to address career navigation, wellbeing and burnout.
🔗: shorturl.at/pS3Fg
Our early-phase trial of DEP-SN38, a poly-lysine dendrimer–conjugated SN38 platform, is now published @ascocancer.bsky.social #JCO @oncocook.bsky.social
💡As TOP1I ADC programs rise, there's growing interest in better payload delivery—and not just through antibodies.
Can dendrimers assist? ⬇️🧵
💡As TOP1I ADC programs rise, there's growing interest in better payload delivery—and not just through antibodies.
Can dendrimers assist? ⬇️🧵
August 6, 2025 at 5:55 PM
Our early-phase trial of DEP-SN38, a poly-lysine dendrimer–conjugated SN38 platform, is now published @ascocancer.bsky.social #JCO @oncocook.bsky.social
💡As TOP1I ADC programs rise, there's growing interest in better payload delivery—and not just through antibodies.
Can dendrimers assist? ⬇️🧵
💡As TOP1I ADC programs rise, there's growing interest in better payload delivery—and not just through antibodies.
Can dendrimers assist? ⬇️🧵
One week until the inaugural #ESMOTATAsia25 🤩
I'm looking forward to joining global drug development experts in🍜🇭🇰
+ sharing insights on dose optimisation of novel combinations
🗓️ Saturday 19 July 2pm.
@myesmo.bsky.social @herbloongmd.bsky.social @anmwongnz.bsky.social
I'm looking forward to joining global drug development experts in🍜🇭🇰
+ sharing insights on dose optimisation of novel combinations
🗓️ Saturday 19 July 2pm.
@myesmo.bsky.social @herbloongmd.bsky.social @anmwongnz.bsky.social
July 11, 2025 at 7:36 PM
One week until the inaugural #ESMOTATAsia25 🤩
I'm looking forward to joining global drug development experts in🍜🇭🇰
+ sharing insights on dose optimisation of novel combinations
🗓️ Saturday 19 July 2pm.
@myesmo.bsky.social @herbloongmd.bsky.social @anmwongnz.bsky.social
I'm looking forward to joining global drug development experts in🍜🇭🇰
+ sharing insights on dose optimisation of novel combinations
🗓️ Saturday 19 July 2pm.
@myesmo.bsky.social @herbloongmd.bsky.social @anmwongnz.bsky.social
Live Webinar @cmri_aus
Unlocking Proteomics for Smarter ADC Development
🗓 Thurs 26 June 2025 | 4–5:15 PM AEST
Join us on mass spec-based proteomics to accelerate and refine ADC development.
events.teams.microsoft.com/event/271eed...
Unlocking Proteomics for Smarter ADC Development
🗓 Thurs 26 June 2025 | 4–5:15 PM AEST
Join us on mass spec-based proteomics to accelerate and refine ADC development.
events.teams.microsoft.com/event/271eed...
Microsoft Virtual Events Powered by Teams
Microsoft Virtual Events Powered by Teams
events.teams.microsoft.com
June 17, 2025 at 10:12 AM
Live Webinar @cmri_aus
Unlocking Proteomics for Smarter ADC Development
🗓 Thurs 26 June 2025 | 4–5:15 PM AEST
Join us on mass spec-based proteomics to accelerate and refine ADC development.
events.teams.microsoft.com/event/271eed...
Unlocking Proteomics for Smarter ADC Development
🗓 Thurs 26 June 2025 | 4–5:15 PM AEST
Join us on mass spec-based proteomics to accelerate and refine ADC development.
events.teams.microsoft.com/event/271eed...
Come work with us St Vincent's Private Hospital Sydney! 🏥🧬🩺
Position for oncology / hematology career medical officer now open:
svha.wd3.myworkdayjobs.com/en-GB/SVHA_S...
Position for oncology / hematology career medical officer now open:
svha.wd3.myworkdayjobs.com/en-GB/SVHA_S...
Oncology/Haematology CMO
Job Description: Better and fairer care. Always. We are St Vincent’s Health Australia, Australia’s largest not-for-profit provider of health and aged care services. Founded by The Sisters of Charity i...
svha.wd3.myworkdayjobs.com
June 16, 2025 at 6:15 PM
Come work with us St Vincent's Private Hospital Sydney! 🏥🧬🩺
Position for oncology / hematology career medical officer now open:
svha.wd3.myworkdayjobs.com/en-GB/SVHA_S...
Position for oncology / hematology career medical officer now open:
svha.wd3.myworkdayjobs.com/en-GB/SVHA_S...
Reposted by Jia (Jenny) Liu MD PhD
Atezolizumab did not improve clinical outcomes in patients with locally advanced squamous cell carcinoma of the head and neck at high risk of disease progression after multimodal definitive treatment.
https://ja.ma/4jVjthY
https://ja.ma/4jVjthY
May 15, 2025 at 6:00 PM
Atezolizumab did not improve clinical outcomes in patients with locally advanced squamous cell carcinoma of the head and neck at high risk of disease progression after multimodal definitive treatment.
https://ja.ma/4jVjthY
https://ja.ma/4jVjthY
Reposted by Jia (Jenny) Liu MD PhD
AACR12 vs AACR25 - Jia Liu
@jiajennyliu.bsky.social @theaacr.bsky.social @kinghorncancer.bsky.social
oncodaily.com/blog/jia-liu...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #AACR25 #AACR12
@jiajennyliu.bsky.social @theaacr.bsky.social @kinghorncancer.bsky.social
oncodaily.com/blog/jia-liu...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #AACR25 #AACR12
Jia Liu: AACR12 vs AACR25 - OncoDaily
Jia Liu: AACR12 vs AACR25 / AACR12, AACR2025, AACR25, cancer, Jia Liu, OncoDaily, Oncology, Patricia LoRusso
oncodaily.com
May 1, 2025 at 7:51 PM
Reposted by Jia (Jenny) Liu MD PhD
Drs. Michael Cecchini and @jiajennyliu.bsky.social co-chair an exciting symposium #AACR25 on new antibody drug conjugate (ADC) and immuno-oncology focused approaches to treating #cancer.
@theaacr.bsky.social
@theaacr.bsky.social
April 28, 2025 at 2:36 PM
Drs. Michael Cecchini and @jiajennyliu.bsky.social co-chair an exciting symposium #AACR25 on new antibody drug conjugate (ADC) and immuno-oncology focused approaches to treating #cancer.
@theaacr.bsky.social
@theaacr.bsky.social
A powerful conclusion to the opening ceremony of #AACR25 - cancer research saves lives 💚 @theaacr.bsky.social
April 27, 2025 at 2:41 PM
A powerful conclusion to the opening ceremony of #AACR25 - cancer research saves lives 💚 @theaacr.bsky.social
Incredible #AACR25 #WICR leadership workshop on now on building resilience in science 🔬🧬💃
loving the networking and open discussions + 🥗🥪🍪
@theaacr.bsky.social @hfpconsulting.bsky.social
loving the networking and open discussions + 🥗🥪🍪
@theaacr.bsky.social @hfpconsulting.bsky.social
April 26, 2025 at 6:42 PM
Incredible #AACR25 #WICR leadership workshop on now on building resilience in science 🔬🧬💃
loving the networking and open discussions + 🥗🥪🍪
@theaacr.bsky.social @hfpconsulting.bsky.social
loving the networking and open discussions + 🥗🥪🍪
@theaacr.bsky.social @hfpconsulting.bsky.social
Great workshop and talk #YingYuan
@mdanderson.bsky.social @fda.gov
on 🔧 backfill strategies in early phase trials including novel BARD covariate-adaptive randomisation strategies allowing dose escalation, backfill and randomisation data to ⏫ efficiency of 🧬 trials #ProjectOptimus #AACR25
@mdanderson.bsky.social @fda.gov
on 🔧 backfill strategies in early phase trials including novel BARD covariate-adaptive randomisation strategies allowing dose escalation, backfill and randomisation data to ⏫ efficiency of 🧬 trials #ProjectOptimus #AACR25
April 25, 2025 at 9:08 PM
Great workshop and talk #YingYuan
@mdanderson.bsky.social @fda.gov
on 🔧 backfill strategies in early phase trials including novel BARD covariate-adaptive randomisation strategies allowing dose escalation, backfill and randomisation data to ⏫ efficiency of 🧬 trials #ProjectOptimus #AACR25
@mdanderson.bsky.social @fda.gov
on 🔧 backfill strategies in early phase trials including novel BARD covariate-adaptive randomisation strategies allowing dose escalation, backfill and randomisation data to ⏫ efficiency of 🧬 trials #ProjectOptimus #AACR25
It’s that time of the year again… Getting ready to 🦹♀️timeshift - heading to @AACR #AACR25 and looking forward to connecting with 🌍 colleagues very soon!
April 23, 2025 at 7:57 AM
It’s that time of the year again… Getting ready to 🦹♀️timeshift - heading to @AACR #AACR25 and looking forward to connecting with 🌍 colleagues very soon!
Reposted by Jia (Jenny) Liu MD PhD
Sacituzumab + Pembro in ASCENT04 improves Progression Free Survival in Patients With Previously Untreated PD-L1 Metastatic Triple-Negative Breast Cancer #bcsm www.gilead.com/news/news-de... @oncoalert.bsky.social
Trodelvy Plus Keytruda Demonstrates a Statistically Significant and Clinically Meaningful Improvement in Progression Free Survival in Patients With Previously Untreated PD L1 Metastatic Triple Negativ...
Trodelvy Plus Keytruda Demonstrates a Statistically Significant and Clinically Meaningful Improvement in Progression Free Survival in Patients With Previously Untreated PD L1 Metastatic Triple Negativ...
www.gilead.com
April 21, 2025 at 11:14 PM
Sacituzumab + Pembro in ASCENT04 improves Progression Free Survival in Patients With Previously Untreated PD-L1 Metastatic Triple-Negative Breast Cancer #bcsm www.gilead.com/news/news-de... @oncoalert.bsky.social
Reposted by Jia (Jenny) Liu MD PhD
Looking forward to the @theaacr.bsky.social Annual Meeting taking place in #Chicago beginning later this week for the latest/greatest in #cancerresearch. Follow the #AACR25 tag and the Social Media Ambassador team for insights throughout the Meeting.
April 21, 2025 at 9:41 PM
Looking forward to the @theaacr.bsky.social Annual Meeting taking place in #Chicago beginning later this week for the latest/greatest in #cancerresearch. Follow the #AACR25 tag and the Social Media Ambassador team for insights throughout the Meeting.
@theaacr.bsky.social #AACR25 meeting less than 2 wks away! I’m looking forward to the clinical trials sessions in this years' meeting 'Unifying Cancer Science and Medicine: a continuum for innovation for impact' 🤝 #PatriciaLorusso
Overview of 37 oral abstracts ⬇️
Overview of 37 oral abstracts ⬇️
April 14, 2025 at 9:27 PM
@theaacr.bsky.social #AACR25 meeting less than 2 wks away! I’m looking forward to the clinical trials sessions in this years' meeting 'Unifying Cancer Science and Medicine: a continuum for innovation for impact' 🤝 #PatriciaLorusso
Overview of 37 oral abstracts ⬇️
Overview of 37 oral abstracts ⬇️
Reposted by Jia (Jenny) Liu MD PhD
🚨New 2 min🎞️summarising step-by-step plan to address fear of #cancer recurrence in clinical practice.
Watch youtu.be/cr_3KEOTAv8?...
Read the 📰 👉 link.springer.com/article/10.1...
Listen to the podcast w/ @bogda-koczwara.bsky.social & Sophie Lebel🎙️ oncologynews.com.au/clinical-foc...
Explanatory🧵👇
Watch youtu.be/cr_3KEOTAv8?...
Read the 📰 👉 link.springer.com/article/10.1...
Listen to the podcast w/ @bogda-koczwara.bsky.social & Sophie Lebel🎙️ oncologynews.com.au/clinical-foc...
Explanatory🧵👇
Step-by-step: A clinical pathway for stepped care management of fear of cancer recurrence
YouTube video by The Daffodil Centre
youtu.be
April 3, 2025 at 5:03 AM
🚨New 2 min🎞️summarising step-by-step plan to address fear of #cancer recurrence in clinical practice.
Watch youtu.be/cr_3KEOTAv8?...
Read the 📰 👉 link.springer.com/article/10.1...
Listen to the podcast w/ @bogda-koczwara.bsky.social & Sophie Lebel🎙️ oncologynews.com.au/clinical-foc...
Explanatory🧵👇
Watch youtu.be/cr_3KEOTAv8?...
Read the 📰 👉 link.springer.com/article/10.1...
Listen to the podcast w/ @bogda-koczwara.bsky.social & Sophie Lebel🎙️ oncologynews.com.au/clinical-foc...
Explanatory🧵👇
Looking forward to joining this stellar team on important webinar on #cancersurvivorship #oncsky
📅 Date: Tuesday, 27 May 2025
⏰ Time: 7:00-8:30PM (UTC+10:00) Canberra, Melbourne, Sydney
➡️ Register today - lnkd.in/gw5GJSZk
📅 Date: Tuesday, 27 May 2025
⏰ Time: 7:00-8:30PM (UTC+10:00) Canberra, Melbourne, Sydney
➡️ Register today - lnkd.in/gw5GJSZk
April 1, 2025 at 6:53 PM
Looking forward to joining this stellar team on important webinar on #cancersurvivorship #oncsky
📅 Date: Tuesday, 27 May 2025
⏰ Time: 7:00-8:30PM (UTC+10:00) Canberra, Melbourne, Sydney
➡️ Register today - lnkd.in/gw5GJSZk
📅 Date: Tuesday, 27 May 2025
⏰ Time: 7:00-8:30PM (UTC+10:00) Canberra, Melbourne, Sydney
➡️ Register today - lnkd.in/gw5GJSZk
Early ✈️ for @sahmriAU South Australian Cancer Research Network planning day representing NSW
➡️ showcasing @NECTANSW as example of successful statewide trials network to facilitate 🔬🏥🧬🧑🧑🧒🧒
Our 28 March Drug Dev Day around the corner!
Reg: oncologydrugdevelopment.weebly.com/registration...
➡️ showcasing @NECTANSW as example of successful statewide trials network to facilitate 🔬🏥🧬🧑🧑🧒🧒
Our 28 March Drug Dev Day around the corner!
Reg: oncologydrugdevelopment.weebly.com/registration...
March 16, 2025 at 6:51 PM
Early ✈️ for @sahmriAU South Australian Cancer Research Network planning day representing NSW
➡️ showcasing @NECTANSW as example of successful statewide trials network to facilitate 🔬🏥🧬🧑🧑🧒🧒
Our 28 March Drug Dev Day around the corner!
Reg: oncologydrugdevelopment.weebly.com/registration...
➡️ showcasing @NECTANSW as example of successful statewide trials network to facilitate 🔬🏥🧬🧑🧑🧒🧒
Our 28 March Drug Dev Day around the corner!
Reg: oncologydrugdevelopment.weebly.com/registration...